The KRM Ayurveda IPO listing delivered exactly what the market loves to see—a confident opening, steady demand, and numbers that tell a clean story.
On Thursday, January 29, KRM Ayurveda stepped into the public markets with strength. The stock listed on the NSE SME platform at ₹172.10, marking a 28% premium over its IPO price of ₹135 per share.
For investors who received allotment, the KRM Ayurveda IPO listing translated into an instant 28% gain on debut day. No drama. No sharp swings. Just a solid start.
Market Performance: A Confident First Day
The tone of the session was clear right from the opening bell.
- IPO Price: ₹135 per share
- Listing Price: ₹172.10 per share
- Listing Gain: 28%
- Platform: NSE SME
The KRM Ayurveda IPO listing stood out for its stability. It wasn’t a flash spike driven by frenzy. It was a measured debut backed by subscription demand and clear business positioning.
Main News: Subscription Strength Reflected on Listing
The strength seen during subscription carried straight into the listing.
The IPO was open from January 21 to January 23, with allotment finalized on January 27. Interest stayed strong across investor categories, creating a solid base for the KRM Ayurveda IPO listing.
Subscription Details:
- Overall Subscription: 74.27 times
- Retail Individual Investors: 54.21 times
- Qualified Institutional Buyers: 63.31 times
- Non-Institutional Investors: 135.37 times
This depth of participation played a key role in the pricing confidence seen on listing day.
Company Details: Business Built on Ayurveda and Scale
KRM Ayurveda operates in the Ayurvedic healthcare space with a mix of physical infrastructure and digital reach.
As of December 31, 2025, the company’s footprint included:
- 6 Ayurvedic hospitals
- 5 Ayurvedic clinics
- 443 employees
- Telemedicine services
- Domestic and overseas product sales
Beyond healthcare services, the company is also involved in the manufacture and sale of Ayurvedic and herbal products, creating multiple revenue touchpoints within the same ecosystem.
This diversified structure adds context to the confidence seen during the KRM Ayurveda IPO listing.
IPO Structure and Fund Utilisation
The issue was structured as a book-built SME IPO, entirely comprising a fresh issue.
IPO Details:
- Total Amount Raised: ₹77.49 crore
- Equity Shares Issued: 57.40 lakh
- Price Band: ₹128 to ₹135 per share
Use of IPO Proceeds:
- Expansion of telemedicine infrastructure
- Technology upgrades
- Repayment of borrowings
- Working capital requirements
- General corporate purposes
The focus remained operational, not speculative—another factor supporting the listing performance.
Financial Snapshot: Clean Numbers, Consistent Margins
Financial performance remained a key pillar behind the KRM Ayurveda IPO listing strength.
Key Financial Data:
- Profit After Tax (FY25): ₹12.1 crore
- Profit After Tax (H1 FY25 – Sept 2025): ₹8.14 crore
- EBITDA Margin: 26.54%
- Return on Net Worth (Sept 2025): 21.84%
These figures highlight operating efficiency and capital discipline without leaning on future projections or assumptions.
Summary: What the KRM Ayurveda IPO Listing Signals?
The KRM Ayurveda IPO listing wasn’t just about a higher opening price. It reflected steady demand, clear financials, and a business model investors understood.
- 28% premium on listing
- Strong participation across investor categories
- ₹77.49 crore raised for operational growth
- Healthy margins and consistent profitability
In a market where SME listings can be unpredictable, the KRM Ayurveda IPO listing delivered clarity. Simple story. Solid numbers. Clean debut.
And sometimes, that’s exactly what the market rewards.
Source: Livemint
Easy & quick
Leave A Comment?